We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Savyon Diagnostics to Spin Off Nongenetic Lab Business

By HospiMedica staff writers
Posted on 17 Jan 2003
An agreement to organize a new Israeli company to acquire the clinical laboratory diagnostics business of Savyon Diagnostics, Ltd., a subsidiary of Healthcare Technologies (Ashdod, Israel), for around US$1.9 million has been announced by Healthcare Technologies, Savyon, and Dr. More...
Martin Lee, founder and former CEO of Great Smokies Diagnostic Laboratory (Ashville, NC, USA).

Healthcare and Dr. Lee will each own 50% of the newly organized company, and Dr. Lee will serve as CEO. Dr. Lee has a Ph.D. in biochemistry and microbiology. His career has included senior positions at many prominent US laboratories. Dr. Nir Navot, current CEO of Savyon Diagnostics, will continue to manage Savyon's clinical laboratory genetic diagnostics business, with the aim of developing it as a leading provider of molecular biology-based tools for the diagnosis of genetically inherited disease.

"The opportunity to work together with such a distinguished senior veteran of the medical diagnostics industry as Dr. Lee makes us all very excited about the future of this new company that we are now creating,” noted Daniel Kropf, president of Healthcare Technologies.





Related Links:
Healthcare Technologies
Great Smokies Lab

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Immunofluorescence Analyzer
IFA System
New
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.